News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|November 21, 2023

Tisotumab Vedotin for Patients With Cervical Cancer

Author(s)Claire Friedman, MD, Emily Davan, RN, Linda Ryan

Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.

Episodes in this series

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 1 Overview of Cervical Cancer

Linda Ryan, a patient advocate

EP. 2 Cervical Cancer: The Patient Journey

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 3 Patient Perceptions of Cervical Cancer Screening

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 4 Treatment Options for Patients With Primary or Recurrent Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 5 Treatments for Patients With Newly Diagnosed Metastatic Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 6 Individualized Treatment Selection in Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 7 Tisotumab Vedotin for Patients With Cervical Cancer

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 8 Unmet Needs in the Cervical Cancer Treatment Landscape

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 9 Shared Decision-Making in Cervical Cancer

Linda Ryan, a patient advocate

EP. 10 Cervical Cancer: Advocating for Yourself and Communicating With Family

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 11 Cervical Cancer: Insight into the Patient Experience

A panel of 3 experts on cervical cancer seated on chairs in a studio

EP. 12 Myths Around Cervical Cancer

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Patient Perspectives on Learning About Their HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Expert Overview of Recurrent/Metastatic HNSCC

ByGlenn Hanna, MD,Andrew Dunning

September 22nd 2025

Final Thoughts and Hope for a Cure

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Future Perspectives in Multiple Myeloma

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Partnering with the Community

ByAmrita Krishnan, MD,Cherry Rudge, NP,Todd Kennedy ,Diane Kennedy

August 12th 2025

Trending on CURE

Tagrisso Plus Chemo Offers Survival benefit in EGFR+ NSCLC

Kisqali Plus Aromatase Inhibitor Shows Long-Term Benefit in Early Breast Cancer

Lenvima Combo Fails to Extend Survival in Esophageal Cancer

Imfinzi Not Associated With Bladder Cancer Quality of Life Decline

Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma

© 2025 MJH Life Sciences^®

All rights reserved.